
Singapore-supervised alternative investment manager running venture, life sciences, real estate and equity strategies

A San Francisco investment fund focused on biotech and drug discovery companies

EcoR1 Capital is an investment fund based in San Francisco that focuses on biotechnology, building long-term partnerships with entrepreneurs working on new therapeutics. It says its role is to support the discovery and development of medicines by backing scientists as they turn research into treatments for patients. The firm points to advances in understanding the molecular basis of disease as the backdrop for its investment approach, and describes itself as contributing to both the science and the strategy behind the companies it backs. EcoR1 Capital has been associated with companies such as Relay Therapeutics and Eikon Therapeutics as part of its portfolio. The firm is based in San Francisco, California.
Profile written by TrustList from the business's own published information, Sep 2026.
2 images — click to enlarge
As of 2026-10-08. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about EcoR1 Capital.
Similar listings buyers compare against this one.

Singapore-supervised alternative investment manager running venture, life sciences, real estate and equity strategies

Biotech venture builder providing pre-seed capital, coaching and connections to founders at the edge of biology and engineering

Tallinn venture fund backing pre-seed to Series A founders from Estonia, Latvia, Lithuania, Finland and Ukraine

Registered investment adviser building public venture, private equity, real estate and credit funds open to non-accredited investors

Uniseed

Healthcare and life sciences investor and operator that backs and scales medical companies, including a surgical products business
Everything here links back to the same verified catalogue. Pick your next stop.